176 related articles for article (PubMed ID: 36115160)
1. The double life of CRISPR-Cas13.
Bot JF; van der Oost J; Geijsen N
Curr Opin Biotechnol; 2022 Dec; 78():102789. PubMed ID: 36115160
[TBL] [Abstract][Full Text] [Related]
2. Applications of the versatile CRISPR-Cas13 RNA targeting system.
Kordyś M; Sen R; Warkocki Z
Wiley Interdiscip Rev RNA; 2022 May; 13(3):e1694. PubMed ID: 34553495
[TBL] [Abstract][Full Text] [Related]
3. Programmable RNA targeting with CRISPR-Cas13.
Shi P; Wu X
RNA Biol; 2024 Jan; 21(1):1-9. PubMed ID: 38764173
[TBL] [Abstract][Full Text] [Related]
4. Optimization of specific RNA knockdown in mammalian cells with CRISPR-Cas13.
Burris BJD; Molina Vargas AM; Park BJ; O'Connell MR
Methods; 2022 Oct; 206():58-68. PubMed ID: 35987443
[TBL] [Abstract][Full Text] [Related]
5. High-fidelity Cas13 variants for targeted RNA degradation with minimal collateral effects.
Tong H; Huang J; Xiao Q; He B; Dong X; Liu Y; Yang X; Han D; Wang Z; Wang X; Ying W; Zhang R; Wei Y; Xu C; Zhou Y; Li Y; Cai M; Wang Q; Xue M; Li G; Fang K; Zhang H; Yang H
Nat Biotechnol; 2023 Jan; 41(1):108-119. PubMed ID: 35953673
[TBL] [Abstract][Full Text] [Related]
6. Negative autoregulation mitigates collateral RNase activity of repeat-targeting CRISPR-Cas13d in mammalian cells.
Kelley CP; Haerle MC; Wang ET
Cell Rep; 2022 Aug; 40(7):111226. PubMed ID: 35977479
[TBL] [Abstract][Full Text] [Related]
7. Applications of CRISPR/Cas13-Based RNA Editing in Plants.
Kavuri NR; Ramasamy M; Qi Y; Mandadi K
Cells; 2022 Aug; 11(17):. PubMed ID: 36078073
[TBL] [Abstract][Full Text] [Related]
8. Insights Gained from RNA Editing Targeted by the CRISPR-Cas13 Family.
Liu L; Pei DS
Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232699
[TBL] [Abstract][Full Text] [Related]
9. A New Method for Programmable RNA Editing Using CRISPR Effector Cas13X.1.
Li L; Liu W; Zhang H; Cai Q; Wen D; Du J; Sun J; Li L; Gao C; Lin P; Wu M; Jiang J
Tohoku J Exp Med; 2023 May; 260(1):51-61. PubMed ID: 36823185
[TBL] [Abstract][Full Text] [Related]
10. Rapidly Characterizing CRISPR-Cas13 Nucleases Using Cell-Free Transcription-Translation Systems.
Wandera KG; Beisel CL
Methods Mol Biol; 2022; 2404():135-153. PubMed ID: 34694607
[TBL] [Abstract][Full Text] [Related]
11. CRISPR-Cas13 System as a Promising and Versatile Tool for Cancer Diagnosis, Therapy, and Research.
Palaz F; Kalkan AK; Can Ö; Demir AN; Tozluyurt A; Özcan A; Ozsoz M
ACS Synth Biol; 2021 Jun; 10(6):1245-1267. PubMed ID: 34037380
[TBL] [Abstract][Full Text] [Related]
12. CRISPR-Cas13 technology portfolio and alliance with other genetic tools.
Wu S; Tian P; Tan T
Biotechnol Adv; 2022 Dec; 61():108047. PubMed ID: 36208845
[TBL] [Abstract][Full Text] [Related]
13. Structure and engineering of the minimal type VI CRISPR-Cas13bt3.
Nakagawa R; Kannan S; Altae-Tran H; Takeda SN; Tomita A; Hirano H; Kusakizako T; Nishizawa T; Yamashita K; Zhang F; Nishimasu H; Nureki O
Mol Cell; 2022 Sep; 82(17):3178-3192.e5. PubMed ID: 36027912
[TBL] [Abstract][Full Text] [Related]
14. Collateral activity of the CRISPR/RfxCas13d system in human cells.
Shi P; Murphy MR; Aparicio AO; Kesner JS; Fang Z; Chen Z; Trehan A; Guo Y; Wu X
Commun Biol; 2023 Mar; 6(1):334. PubMed ID: 36977923
[TBL] [Abstract][Full Text] [Related]
15. CRISPR guides induce gene silencing in plants in the absence of Cas.
Sharma VK; Marla S; Zheng W; Mishra D; Huang J; Zhang W; Morris GP; Cook DE
Genome Biol; 2022 Jan; 23(1):6. PubMed ID: 34980227
[TBL] [Abstract][Full Text] [Related]
16. Intrinsic targeting of host RNA by Cas13 constrains its utility.
Li Z; Li Z; Cheng X; Wang S; Wang X; Ma S; Lu Z; Zhang H; Zhao W; Chen Z; Yao Y; Zhang C; Chao L; Li W; Fei T
Nat Biomed Eng; 2024 Feb; 8(2):177-192. PubMed ID: 37872368
[TBL] [Abstract][Full Text] [Related]
17. RNA-Targeting CRISPR-Cas Systems and Their Applications.
Burmistrz M; Krakowski K; Krawczyk-Balska A
Int J Mol Sci; 2020 Feb; 21(3):. PubMed ID: 32046217
[TBL] [Abstract][Full Text] [Related]
18. Programmable RNA base editing with photoactivatable CRISPR-Cas13.
Yu J; Shin J; Yu J; Kim J; Yu D; Heo WD
Nat Commun; 2024 Jan; 15(1):673. PubMed ID: 38253589
[TBL] [Abstract][Full Text] [Related]
19. Progress of CRISPR-based programmable RNA manipulation and detection.
Wang B; Yang H
Wiley Interdiscip Rev RNA; 2023; 14(6):e1804. PubMed ID: 37282821
[TBL] [Abstract][Full Text] [Related]
20. Precise transcript targeting by CRISPR-Csm complexes.
Colognori D; Trinidad M; Doudna JA
Nat Biotechnol; 2023 Sep; 41(9):1256-1264. PubMed ID: 36690762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]